ConductScience.org, home

Paper22129166

Effect of pregnancy on emtricitabine pharmacokinetics.

Stek AM and 12 others. HIV Med, 2012. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Effect of pregnancy on emtricitabine pharmacokinetics. Papers, record 22129166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22129166

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of pregnancy on emtricitabine pharmacokinetics.
PubMed
Journal
HIV Med
PubMed
Year
2012
PubMed
Publication types
Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.61
iCite
Revised in PubMed
2025-05-29
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stek AMA M
2Best BMB M
3Luo WW
4Capparelli EE
5Burchett SS
6Hu CC
7Li HH
8Read JSJ S
9Jennings AA
10Barr EE
11Smith EE
12Rossi SSS S
13Mirochnick MM

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
DeoxycytidineMajor topic
HIV InfectionsMajor topic
Pregnancy Complications, InfectiousMajor topic
Adult
Area Under Curve
Emtricitabine
Female
Humans
Inhibitory Concentration 50
Metabolic Clearance Rate
Postpartum Period
Pregnancy
Pregnancy Trimester, Third
Prospective Studies
Viral Load
Young Adult

Source PubMed

Download CSV of topics

Grants11

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
HHSN267200800001GNIDDK NIH HHSUnited StatesPubMedPubMed
U01 AI068632NIAID NIH HHSUnited StatesU01AI068632PubMed and NIHNIH RePORTER
UM1 AI068632NIAID NIH HHSUnited StatesU01AI068632PubMed and NIHNIH RePORTER
U01 AI068616NIAID NIH HHSUnited StatesU01AI068616PubMed and NIHNIH RePORTER
HHSN267200800001CNICHD NIH HHSUnited StatesPubMedPubMed
U01 AI041110NIAID NIH HHSUnited StatesU01AI041110PubMed and NIHNIH RePORTER
M01 RR000043NCRR NIH HHSUnited StatesM01RR000043PubMed and NIHNIH RePORTER
AI068632NIAID NIH HHSUnited StatesU01AI068632PubMed and NIHNIH RePORTER
1 U01 AI068616NIAID NIH HHSUnited StatesU01AI068616PubMed and NIHNIH RePORTER
5 U01 AI41110NIAID NIH HHSUnited StatesU01AI041110PubMed and NIHNIH RePORTER
UM1AI068632NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00042289Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After PregnancyResults

Source ClinicalTrials.gov

Download CSV of trials

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19780252Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring.J Infect Dis1998https://conductscience.org/library/papers/9780252PubMed
217414929Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137.J Acquir Immune Defic Syndr2007https://conductscience.org/library/papers/17414929PubMed
315588339Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection.AIDS Res Hum Retroviruses2004https://conductscience.org/library/papers/15588339PubMed
419104016Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19104016PubMed
516470119Impact of pregnancy on abacavir pharmacokinetics.AIDS2006https://conductscience.org/library/papers/16470119PubMed
621283017Atazanavir pharmacokinetics with and without tenofovir during pregnancy.J Acquir Immune Defic Syndr2011https://conductscience.org/library/papers/21283017PubMed
717519400Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers.J Clin Pharmacol2007https://conductscience.org/library/papers/17519400PubMed
821078458Antiretroviral pharmacology: special issues regarding pregnant women and neonates.Clin Perinatol2010https://conductscience.org/library/papers/21078458PubMed
915551216Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332.J Infect Dis2004https://conductscience.org/library/papers/15551216PubMed
108098905
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group.
Am J Obstet Gynecol1993https://conductscience.org/library/papers/8098905PubMed
1120632458Lopinavir tablet pharmacokinetics with an increased dose during pregnancy.J Acquir Immune Defic Syndr2010https://conductscience.org/library/papers/20632458PubMed
127758253Placental transfer of drugs administered to the mother.Clin Pharmacokinet1995https://conductscience.org/library/papers/7758253PubMed
1315504861Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15504861PubMed
1416988514Reduced lopinavir exposure during pregnancy.AIDS2006https://conductscience.org/library/papers/16988514PubMed
1520622674Suboptimal nevirapine steady-state pharmacokinetics during intrapartum compared with postpartum in HIV-1-seropositive Ugandan women.J Acquir Immune Defic Syndr2010https://conductscience.org/library/papers/20622674PubMed
1614982771Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratories.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/14982771PubMed
1717526857Pharmacokinetic evaluation of emtricitabine in combination with other nucleoside antivirals in healthy volunteers.J Clin Pharmacol2007https://conductscience.org/library/papers/17526857PubMed
1818366444Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics.HIV Med2008https://conductscience.org/library/papers/18366444PubMed
1915905735Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life.J Acquir Immune Defic Syndr2005https://conductscience.org/library/papers/15905735PubMed
209391746Pharmacokinetic changes during pregnancy and their clinical relevance.Clin Pharmacokinet1997https://conductscience.org/library/papers/9391746PubMed

See all 21 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42090286Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy.J Antimicrob Chemother2026https://conductscience.org/library/papers/42090286PubMed
41901296From Pharmacovigilance Signals to Mechanistic Phenotypes: Integrating ADMET, PK/PD, and Network Context to Interpret Antiviral Safety in Pregnancy.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41901296PubMed
39487018Care of Pregnant Women Living with Human Immunodeficiency Virus.Clin Perinatol2024https://conductscience.org/library/papers/39487018PubMed
35067869Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.Clin Pharmacokinet2022https://conductscience.org/library/papers/35067869PubMed
33527213Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir.Clin Pharmacokinet2021https://conductscience.org/library/papers/33527213PubMed
32592111Drug dosing during pregnancy-opportunities for physiologically based pharmacokinetic models.J Pharmacokinet Pharmacodyn2020https://conductscience.org/library/papers/32592111PubMed
31529598Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?J Int AIDS Soc2019https://conductscience.org/library/papers/31529598PubMed
31489678Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir.J Clin Pharmacol2020https://conductscience.org/library/papers/31489678PubMed
31160284Multiple Drug Transporters Contribute to the Placental Transfer of Emtricitabine.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/31160284PubMed
29369162Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV.AIDS2018https://conductscience.org/library/papers/29369162PubMed
28426519Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feeding.Curr Opin HIV AIDS2017https://conductscience.org/library/papers/28426519PubMed
27802281Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review.PLoS Med2016https://conductscience.org/library/papers/27802281PubMed
27490637Advancing HIV research with pregnant women: navigating challenges and opportunities.AIDS2016https://conductscience.org/library/papers/27490637PubMed
26518984Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.Br J Clin Pharmacol2016https://conductscience.org/library/papers/26518984PubMed
26011128Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.Br J Clin Pharmacol2015https://conductscience.org/library/papers/26011128PubMed
25407158Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics.HIV Med2015https://conductscience.org/library/papers/25407158PubMed
25281357Basic obstetric pharmacology.Semin Perinatol2014https://conductscience.org/library/papers/25281357PubMed
25223699Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.Clin Pharmacokinet2014https://conductscience.org/library/papers/25223699PubMed
24995851Modified renal function in pregnancy: impact on emtricitabine pharmacokinetics.Br J Clin Pharmacol2014https://conductscience.org/library/papers/24995851PubMed
24575394Obstetric Pharmacokinetic Dosing Studies are Urgently Needed.Front Pediatr2014https://conductscience.org/library/papers/24575394PubMed

See all 22 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CYP4F34051PubTator's text mininghttps://conductscience.org/library/genes/4051NCBI Gene
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene
SLC17A526503PubTator's text mininghttps://conductscience.org/library/genes/26503NCBI Gene

Download CSV of genes

Drugs40

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
AMPRENAVIRCHEMBL116Results1https://conductscience.org/library/drugs/CHEMBL116ChEMBL
ATAZANAVIRCHEMBL1163Results1https://conductscience.org/library/drugs/CHEMBL1163ChEMBL
AMINOSALICYLIC ACIDCHEMBL1169Results1https://conductscience.org/library/drugs/CHEMBL1169ChEMBL
DOLUTEGRAVIRCHEMBL1229211Results1https://conductscience.org/library/drugs/CHEMBL1229211ChEMBL
LINEZOLIDCHEMBL126Results1https://conductscience.org/library/drugs/CHEMBL126ChEMBL
DARUNAVIRCHEMBL1323Results1https://conductscience.org/library/drugs/CHEMBL1323ChEMBL
ABACAVIRCHEMBL1380Results1https://conductscience.org/library/drugs/CHEMBL1380ChEMBL
KANAMYCINCHEMBL1384Results1https://conductscience.org/library/drugs/CHEMBL1384ChEMBL
ETHIONAMIDECHEMBL1441Results1https://conductscience.org/library/drugs/CHEMBL1441ChEMBL
DIDANOSINECHEMBL1460Results1https://conductscience.org/library/drugs/CHEMBL1460ChEMBL
ETONOGESTRELCHEMBL1531Results1https://conductscience.org/library/drugs/CHEMBL1531ChEMBL
EMTRICITABINE, (+/-)-CHEMBL161381Results1https://conductscience.org/library/drugs/CHEMBL161381ChEMBL
FOSAMPRENAVIRCHEMBL1664Results1https://conductscience.org/library/drugs/CHEMBL1664ChEMBL
RILPIVIRINECHEMBL175691Results1https://conductscience.org/library/drugs/CHEMBL175691ChEMBL
AMIKACINCHEMBL177Results1https://conductscience.org/library/drugs/CHEMBL177ChEMBL
COBICISTATCHEMBL2095208Results1https://conductscience.org/library/drugs/CHEMBL2095208ChEMBL
TERIZIDONECHEMBL2107553Results1https://conductscience.org/library/drugs/CHEMBL2107553ChEMBL
DELAMANIDCHEMBL218650Results1https://conductscience.org/library/drugs/CHEMBL218650ChEMBL
CAPREOMYCINCHEMBL2221250Results1https://conductscience.org/library/drugs/CHEMBL2221250ChEMBL
TIPRANAVIRCHEMBL222559Results1https://conductscience.org/library/drugs/CHEMBL222559ChEMBL

See all 40 drugsDownload CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22129166

GET https://conductscience.org/api/papers/v1/22129166/references?page=2